Ani Pharmaceuticals (ANIP) Interest Expenses (2010 - 2026)
Ani Pharmaceuticals (ANIP) posted Interest Expenses of $38.6 million for Q1 2026, up 276.46% sequentially from $10.2 million in Q4 2025, and down 16.79% YoY from $46.3 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Interest Expenses (2010 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Interest Expenses for 17 years, with the latest figure at $38.6 million in Q1 2026.
- Quarterly Interest Expenses fell 16.79% year-over-year to $38.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.6 million (down 16.79% YoY) and the FY2025 annual result came in at $48.3 million, down 6.19% from the prior year.
- Interest Expenses climbed to $38.6 million in Q1 2026 per ANIP's latest filing, from $10.2 million in the prior quarter.
- Over five years, Interest Expenses peaked at $51.8 million in Q3 2024 and troughed at $8.8 million in Q4 2024.
- A 5-year average of $30.0 million and a median of $31.4 million in 2023 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2022 and 2024: Interest Expenses jumped 224.78% in 2022, then sank 72.01% in 2024.
- Over 5 years, Interest Expenses stood at $14.5 million in 2022, then soared by 116.99% to $31.4 million in 2023, then tumbled by 72.01% to $8.8 million in 2024, then gained by 16.42% to $10.2 million in 2025, then surged by 276.46% to $38.6 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $38.6 million, $10.2 million, and $48.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.00 Mn |
| Jun 30, 2026 | 14.00 Mn |
| Mar 31, 2026 | 38.57 Mn |
| Mar 31, 2026 | 38.57 Mn |
| Dec 31, 2025 | 10.24 Mn |
| Dec 31, 2025 | 10.24 Mn |
| Sep 30, 2025 | 48.32 Mn |
| Sep 30, 2025 | 48.32 Mn |
| Jun 30, 2025 | 48.36 Mn |
| Jun 30, 2025 | 48.36 Mn |
| Mar 31, 2025 | 46.35 Mn |
| Mar 31, 2025 | 46.35 Mn |
| Dec 31, 2024 | 8.80 Mn |
| Dec 31, 2024 | 8.80 Mn |
| Sep 30, 2024 | 51.78 Mn |
| Sep 30, 2024 | 51.78 Mn |
| Jun 30, 2024 | 18.36 Mn |
| Jun 30, 2024 | 18.36 Mn |
| Mar 31, 2024 | 18.36 Mn |
| Mar 31, 2024 | 18.36 Mn |